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Abstract: Despite the fact that American Heart Association (AHA) recommended a systematic
screening for depression in cardiovascular inpatients, poor attention has been given to this issue.
Furthermore, no specific guidelines exist for anxiety screening in cardiovascular inpatients. Thus,
the aims of this study were to verify the feasibility of a depressive and anxiety symptoms screening
protocol in an Italian hospital specializing in cardiovascular diseases and to evaluate both anxiety and
depressive symptoms prevalence. A group of 2009 consecutive inpatients completed the 9-item Patient
Health Questionnaire (PHQ-9) and the 7-item Generalized Anxiety Disorder (GAD-7). The rates of
depressive and anxiety symptoms were almost 9% and 16% respectively. Men were less likely than
women to experience both depressive and anxiety symptoms. Patients who were admitted to the
heart failure unit reported higher risk of experiencing both symptoms compared to patients in other
wards. Similarly, patients admitted to the cardiac surgery unit showed a higher risk of experiencing
anxiety symptoms compared to other patients. The proposed screening procedure showed a good
feasibility and acceptance. This study highlighted the importance of implementing a short screening
procedure in hospitals dealing with cardiovascular inpatients to identify those individuals who
require specific attention and interventions.
Keywords: cardiovascular diseases (CVD); depressive symptoms; anxiety symptoms; health
psychology; screening; PHQ-9; GAD-7
1. Introduction
Major Depressive Disorder (MDD), commonly referred as depression, is a highly prevalent mental
diseases, with more than 300 million people affected worldwide and it has been consistently associated
with increased risk of cardiovascular diseases (CVD) [1]. The prevalence of depression in CVD patients
is about 15–30% [2], which is two-to-three times more than in the general population. Many studies
also indicate that patients diagnosed with depression show a 60% higher risk of developing CVD
compared to healthy controls [3]. In patients with CVD, depression is independently associated with
poor prognosis and poor health-related quality of life, and disability, recurrent cardiac events, and high
mortality [4]. Such findings have been confirmed by a recent European Society of Cardiology (ESC)
position paper [5], in which the authors showed that depression following acute coronary syndrome
(ACS) significantly increases mortality risk. In the same paper, it has been also shown that patients with
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comorbid depression and stable coronary heart disease (CHD) demonstrate low adherence to treatments
and high resistance to lifestyle changes; they are also unlikely to participate in cardiac rehabilitation
programs and they are likely to drop out from them [5]. In 2008, this evidence drove the American
Heart Association (AHA) to propose a screening process consisting in a primary administration of the
2-item Patient Health Questionnaire (PHQ-2), eventually followed by a further assessment with the
9-items Patients Health Questionnaire (PHQ-9) and, if necessary, by a psychological assessment [6].
A few years after the publication of the AHA guidelines, Sowden and colleagues conducted a study
to evaluate the feasibility of a hospital inpatient’s cardiac unit, finding that it is sufficiently feasible
and it does not require intensive resource, to be implemented [4]. Unfortunately, despite the existence
of specific recommendations and the evidence supporting their applicability in hospital settings,
depression is still often unrecognized and rarely assessed and treated in CVD patients [7].
In addition to depression, anxiety symptoms and anxiety disorders, such as Generalized Anxiety
Disorder (GAD) and Panic Disorder (PD), are known to be significantly associated with both CVD
onset and progression [7], with the aggravating circumstance that anxiety is even more common than
depression being present in more than 50% of patients with heart failure. According to Celano and
colleagues, the relationship between anxiety and CVD is a complex and unclear issue and, though no
model exists, several hypotheses include both behavioral (i.e., less healthy diet, low physical activity,
reduced treatment adherence and more smoking) and physiologic factors (i.e., autonomic, endothelial
and platelet dysfunction and inflammation processes) as possible determinants of such comorbidity [7].
Similar to depression, despite all the existing evidences displays the link between CVD and anxiety,
no systematic programs have assessed and treated anxiety in inpatients with CVD [8].
Based on the lack of systematic interventions on cardiac patients, the Psychocardiology Team
operating at Centro Cardiologico Monzino (CCM), an Italian hospital dedicated to the prevention and
treatment of cardiovascular patients, implemented a short screening program based on two validated
psychological questionnaires. The two aims of the study included: (1) analyzing the overall feasibility
and acceptance of this approach to identify depression and/or anxiety symptoms in inpatients with
cardiac illnesses; and (2) identifying the relative prevalence of these two symptoms in such specific
cohort of patients.
2. Materials and Methods
2.1. Sample
The sample initially consisted of 2515 consecutively admitted inpatients to CCM for a cardiac
disease. Of the initial sample, 2009 (79.88%) completed the questionnaires, while 506 of them (20.12%)
returned them blank or incomplete. The recruitment period lasted 6 months (from January 2019 to
July 2019). Institutional Review Board approval was obtained for this study, and all patients provided
informed consent before completing the questionnaires.
2.2. The Screening Procedure
As part of the hospital admission procedure, each patient received a brief survey about personal and
anamnestic data and two validated self-report questionnaires: the 9-item Patient Health Questionnaire
(PHQ-9) [9] to assess depressive symptoms and the 7-item Generalized Anxiety Disorder [10] to
assess anxiety symptoms. At the end of the survey, the ninth item of the Beck Depression Inventory-II
(BDI-II) [11] (i.e., a question related to suicidal ideation) was added. The completed questionnaires
were collected daily by a psychologist of the Centro Cardiologico Monzino Psychocardiology Team
(CCM-PT), who systematically checked them to determine which patients scored above the cutoff.
Those patients whose scores were above the cutoff for depressive and/or anxiety symptoms underwent
a clinical assessment with a psychologist of the CCM-PT. Those patients who rated the presence of
suicidal risk were immediately visited by a CCM-PT psychologist and, in case of real suicidal ideation,
also by a psychiatrist.
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2.3. Questionnaires
2.3.1. 9-Item Patient Health Questionnaire (PHQ-9)
Depressive symptoms were assessed using the PHQ-9 [9]. PHQ-9 was chosen because of its
reliability, simplicity, speed of use, its high correlation with formal interview for MDD diagnosis [9,12]
and because it is recommended by the AHA screening guidelines [6]. The PHQ-9 is made of 9 items
investigating different depression domains whose scores range from 0 to 3 (total score range: 0–27).
According to the AHA guidelines, a PHQ-9 score of 10 should be used as cutoff for depression [6].
2.3.2. 7-Item General Anxiety Disorder (GAD-7)
Anxiety symptoms were assessed using the GAD-7 [10], a questionnaire composed by 7 items,
recommended for the screening of anxiety in CVD patients by Conway and colleagues [13]. The total
GAD-7 score ranges from 0 to 21, with a cutoff of 8 indicating the presence of significant anxiety symptoms.
2.3.3. Suicidal Risk
At the end of the survey, the ninth item of the Beck Depression Inventory-II [11] was administered
in order to evaluate the patient’s suicidal risk. Patients had to choose one option between the following
four alternatives: (0) I don’t have any thoughts of killing myself; (1) I have thoughts of killing myself,
but I would not carry them out; (2) I would like to kill myself; (3) I would kill myself if I had the chance.
2.4. Statistical Analysis
Continuous variables are presented as mean ± standard deviation (SD) if normally distributed
or median and interquartile ranges (IQR) if not normally distributed, while categorical variables
are presented as absolute numbers and percentages. Chi-square tests were implemented to assess
sex difference between groups (under/above cut- off of PHQ-9 or GAD-7). To identify independent
predictors of depression or anxiety two logistic regression analysis were performed. All tests were
two-sided, and a p-value < 0.05 was required for statistical significance. All calculations were computed
using the SAS software package (Version 9.4 SAS Institute Inc., Cary, NC, USA).
3. Results
3.1. Demographic and Clinical Characteristics
The sample primarily consists of men and patients over the age of 60, with a low-medium
education. Most of the patients were married and they were admitted to the invasive cardiology or the
arrhythmology wards. The median length of hospital stay was 2 days (Table 1).
3.2. Psychological Characteristics
Approximately 18% of patients scores were above the cutoff: 9% of them showed anxiety symptoms,
3% depressive symptoms and 6% both anxiety and depressive symptoms (Table 2). Regarding the
suicidal ideation, 2% of the patients declared to have experienced it, while another 2% (n = 43) did not
answer the question.
In general, women showed both higher depressive and anxiety symptoms than men (Table 3).
The PHQ-9 score was also positively correlated with the length of hospital stay (r = 0.052; p = 0.020),
despite the r value is very small.
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Table 1. Demographic and clinical characteristics of the sample.
Mean/Median SD/IQR 1 N
Age (mean; SD) 64.0 14.6 2006
Education (mean; SD) 11.6 4.4 1746
Length of Hospital Stay (median; IQR) 2 1–4 1973
Frequency Percentage N
Sex
Men 1426 70.98
2009Women 583 29.02
Marital
Status
Single 204 10.26
1989
Unmarried Couples 91 4.58
Married Couples 1366 68.68
Divorced 149 7.49
Widowed 179 9.0
Hospital
Ward
Heart Failure 232 11.61
1998
Clinical Cardiology 88 4.4
Cardiac Surgery 323 16.17
Arrhythmology 632 31.63
Invasive Cardiology 723 36.19
1 SD, Standard Deviation; IQR, Interquartile Range.
Table 2. Psychological characteristics of the sample.
GAD-7 1
Under Cutoff Above Cutoff Total
PHQ-9 2
Under Cutoff 1642 (81.8%) 189 (9.4%) 1831 (91.1%)
Above Cutoff 53 (2.6%) 125 (6.2%) 178 (8.9%)
Total 1695 (84.4%) 314 (15.6%) 2009
Frequency Percentage
Suicidal
Ideation 3
I don’t have any thoughts of killing myself 1926 98.0
I have thoughts of killing myself, but I would
not carry them out 33 1.7
I would like to kill myself 6 0.3
I would like to kill myself if I had the chance 1 0.1
1 GAD-7, 7-item General Anxiety Disorder; 2 PHQ-9, 9-item Patients Health Questionnaire; 3 Suicidal Ideation,
9th item of the Beck Depression Inventory-II (BDI-II).
Table 3. Sex and psychological characteristics of the sample.
Men Women
p-Value 3
Frequency Percentage Frequency Percentage
GAD-7 1
Under Cutoff 1239 86.9 456 78.22
<0.001Above Cutoff 187 13.1 127 21.8
PHQ-9 2
Under Cutoff 1329 93.2 502 86.1
<0.001Above Cutoff 97 6.8 81 13.9
1 GAD-7, 7-item General Anxiety Disorder; 2 PHQ-9, 9-item Patients Health Questionnaire; 3 The p-values are related
to Chi-square test.
3.3. Anxiety and Depressive Symptoms across the Hospital Wards
Both heart failure and cardiac surgery wards showed the highest row percentage of patients with
anxiety and depressive symptoms above the cutoff (Table 4).
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Table 4. Depressive and anxiety symptoms in the different hospital wards.
PHQ-9 1 GAD-7 2
Under Cutoff Above Cutoff Under Cutoff Above Cutoff
N (row %) N (row %) N (row %) N (row %)
Hospital
Wards
Heart Failure 194 (83.62) 38 (16.38) 181 (78.02) 51 (21.98)
Clinical Cardiology 81 (92.05) 7 (7.95) 76 (86.36) 12 (13.64)
Cardiac Surgery 290 (89.78) 33 (10.22) 261 (80.80) 62 (19.20)
Arrhythmology 587 (92.88) 45 (7.12) 542 (85.76) 90 (14.24)
Invasive Cardiology 668 (92.39) 55 (7.61) 625 (86.45) 98 (13.55)
1 PHQ-9, 9-item Patients Health Questionnaire; 2 GAD-7, 7-item General Anxiety Disorder.
Multivariate analysis shows that patients admitted to the heart failure ward have a 2.6 higher
risk of presenting depressive symptoms compared to patients admitted in the other wards and that
men are 51% less likely than women to experience depressive symptoms. Similar results were found
for anxiety symptoms. Patients admitted to the heart failure, but also to the cardiac surgery wards,
have respectively a 1.8 and a 1.4 higher risk of presenting anxiety symptoms compared to the patients
admitted in the other wards. Moreover, men were found to be 42% less likely than women to experience
anxiety symptoms. Finally, education acts as protective factor for anxiety, as shown by the fact that
higher educated patients experience less anxiety symptoms (−21% for each unit) compared to the
others. All the results are showed in Table 5.
Table 5. Multivariate analysis: Risk factors for both anxiety and depressive symptoms.
PHQ-9 1 GAD-7 2
OR 95% CI OR 95%CI
Age 1.01 1.000–1.206 1.00 0.986–1.006
Sex (women) 0.49 0.340–0.700 * 0.58 0.434–0.770 *
Education 0.92 0.765–1.110 0.79 0.677–0.913 *
Marital Status 3
Single and Divorced 1.24 0.771–1.981 0.93 0.638–1.365
Widowed 1.25 0.710–2.212 0.80 0.483–1.341
Hospital Wards 4
Cardiac Surgery 1.42 0.900–2.230 1.43 1.005–2.029 *
Heart Failure 2.59 1.678–4.000 * 1.83 1.250–2.665 *
1 PHQ-9, 9-item Patients Health Questionnaire; 2 GAD-7, 7-item General Anxiety Disorder; 3 The Marital Status
reference category is Couples, which includes both Unmarried and Married Couples; 4 The Hospital Wards reference
category is Other Wards, which includes Clinical Cardiology, Arrhythmology and Invasive Cardiology. * boldface
indicates a p < 0.05.
4. Discussion
The present study represents the first attempt to perform a systematic psychological screening
of all patients consecutively admitted during a 6-month period in an Italian hospital specialized in
cardiac diseases. Starting from the increasing evidence of a link between CVDs, depression and anxiety,
we have implemented a screening procedure, partially based on the AHA guidelines, that allowed
us to investigate both depression and anxiety in cardiac inpatients in a simple and quick way.
The screening was based on the administration of PHQ-9 and GAD-7, which are two validated
self-report questionnaires widely used in cardiovascular literature. The assessment was completed
with a specific question about the presence of suicidal thoughts, extracted from the BDI-II questionnaire.
All the patients who obtained a score above the cutoff for depression, anxiety or both received a
further psychological assessment performed by a clinical psychologist, followed, when necessary,
by a number of personalized support sessions. Moreover, those patients who positively answered the
suicidal ideation question were immediately visited by a clinical psychologist for an effective suicidal
risk evaluation.
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4.1. Feasibility and Acceptance
One of the main aims of this study was to evaluate the screening procedure feasibility and
acceptance. Regarding this issue, we observed that almost 80% of patients completed the questionnaires,
spending on average 5 to 10 min completing them. The need of evaluating its feasibility and acceptance
came from the fact that our procedure is, for two reasons, partially different from the procedures
proposed by the AHA. First, we could not use the PHQ-2 as first step of the screening because it is
not validated in Italian. Second, we added a screening procedure for anxiety that was not included
in the AHA guidelines. Despite these changes, our data suggest that the implemented screening
procedure was feasible, effective, and well-accepted by the majority of patients. Nevertheless, to really
integrate it in the everyday clinical practice, we recommend that patients receive and complete the
questionnaires once they are admitted in the hospital wards as part of their routine clinical assessment,
instead of during the acceptance phase. In our opinion, these changes will further increase the patients’
adherence rate to the survey, as well as the physicians and nurses’ involvement in the screening
process itself, giving them the concrete opportunity to use the collected psychological data to provide
a more personalized treatment to the patients, taking into account their clinical condition, and their
psychological status [14].
4.2. Depressive and Anxiety Symptoms Prevalence
Since, to our knowledge, no other studies have systematically investigated the prevalence of
both depression and anxiety symptoms in cardiovascular diseases in Italy. Therefore, we can only
compare our data with the data obtained from the general Italian population and from those available
in the international literature. Compared to the general Italian population, our sample of CVD patients
shows a prevalence of depressive and anxiety symptoms (i.e., almost 9% and 16% respectively) that
is, respectively, three and four times higher. These data are in line with the majority of the results
obtained in other countries, even if both the methodological (i.e., the sample size differences among
studies, the use of different screening tools each with a specific cutoff) and the clinical (i.e., the type of
cardiac diseases evaluated) differences among the different studies, as well as the heterogeneity in the
patients’ recruitment timing (i.e., during the pre- or post-operative period) and in the patients’ previous
psychopathological and cardiac history, may significantly affects anxiety and depressive symptoms
bringing to heterogeneous data about their effective prevalence [15]. To reduce this heterogeneity,
a shared and unique strategy to collect psychological data from CVD patients should be implemented.
This strategy would help both cardiologists and psychologists to better identify the incidence of
psychological symptoms across CVD patients and to develop new synergies to better understand the
link between heart and mind.
4.3. Depressive and Anxiety Symptoms Prevalence in the Hospital Wards
We found significant differences in the prevalence of psychological symptoms among different
clinical wards. In particular, we observed that patients admitted to the heart failure ward showed
a higher risk of presenting both depressive (i.e., 2.5 higher) and anxiety (i.e., 1.8 higher) symptoms
compared to those patients admitted in the other wards. This result is not surprising if we consider
that heart failure is frequently associated with poor physical functioning and with an impaired
health-related quality of life, as well as with frequent hospitalizations and a high prevalence of
depressive and anxiety symptoms in non-hospitalized patients [16]. In addition, patients with heart
failure show a high rate of recurrence, leading to frequent chronic condition (i.e., Chronic Heart
Failure, CHF) characterized by multiple episodes that can lead to an increase of depressive and anxiety
symptoms [16]. Patients admitted to the cardiac surgery ward also showed a higher risk of presenting
anxiety symptoms (i.e., 1.4 times higher) compared to the other patients. This result is in line with
previous studies showing a high prevalence of anxiety symptoms in the preoperative phase of cardiac
surgery [17–20] mainly caused by the fear and uncertainty related to the surgical procedure [19].
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Even if these results can be easily explained by the presence of a certain diagnosis (i.e., heart failure)
or condition (i.e., pre-operative status) such data may be very useful to predict the hospital wards or
services that need psychological support and interventions.
4.4. Depressive Symptoms and Length of Hospital Stay
Another interesting result is that the severity of depressive symptoms, but not of anxiety
symptoms, positively correlates with the time spent in the hospital (i.e., length of hospital stay, LHS).
Previous studies about this issue were specifically focused on the link between preoperative depressive
symptoms and the length of hospital stay showing heterogeneous results: some of them found a
significant link between the two [21–23], whereas some other studies did not find any association [24].
Nevertheless, our sample is not entirely composed of preoperative patients, so our results involve
even other clinical conditions and could be explained perhaps by the fact that pre-existing depressive
symptomatology may put a strain on the patient’s physical and mental resources leading to a slower
recovery time. Again, these data underline the need of activating specific psychological interventions
for depressed inpatients with the primary aim of improving their well-being and the secondary aim of
reducing the length of hospital stay with possible positive effects on the health care costs.
4.5. Depressive and Anxiety Symptoms in Men and Women
We were also interested in understanding if the prevalence of depressive and anxiety symptoms
were different between men and women even in the context of cardiovascular diseases. In line
with previous data about the incidence of these psychological symptoms in the general population,
and with a recent paper of Buckland and colleagues [25], we found that women with cardiovascular
diseases are more likely than men with cardiovascular diseases of manifesting anxiety and depressive
symptoms [26].
4.6. Education as Protective Factor against Anxiety Symptoms
Finally, a very interesting issue arising from our data regards the role of education as protective
factor against anxiety symptoms. This result may be explained by the fact that education gives the
possibility to enhance access to health-related information that may help patients to better cope with
their illnesses and treatments and to increase their empowerment. This explanation was also discussed
in the study conducted by Bjelland and colleagues, in which the authors stated that high educational
level seems to protect against both anxiety and depression [27].
4.7. Limitations
The main limitation of this study is the heterogeneity of the sample. The two aims of the study
included: (1) analyzing the feasibility of the proposed screening method in the population of CVD
patients admitted in the hospital and (2) identifying the prevalence of depressive and anxiety symptoms
on the entire sample for a period of 6 consecutive months. To achieve these aims, we decided to include
all the patients regardless of their pre-existing psychopathological conditions and their past clinical
history. Moreover, the adopted data collection did not allow us to collect very specific information
about their actual diagnosis. Nevertheless, this approach allowed us to verify the feasibility of applying
a screening procedure for depression and anxiety in a real clinical context obtaining very satisfactory
results in terms of adherence and knowledge and opening concrete possibilities to create new synergies
between the field of cardiology and psychology.
5. Conclusions
Our data confirm the increased prevalence of depression and anxiety symptoms in CVD patients
supporting the urgent need of developing new strategies to further improve the screening procedures in
the cardiovascular patient care process. In particular, we argue that 5 issues are of primary importance.
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The first one is to implement structured screening procedures also for anxiety symptoms and not
only for depressive ones. The second one is to include psychological screening procedures for CVD
patients in the hospital routine. The third one is to make both physicians and nurses more aware of the
frequent cardiovascular and psychological comorbidity and to give them a directs access to the patient’s
psychological data. The fourth one is to specifically monitor the hospital wards that are at most risk
of having patients with psychological disorders and to develop psychological support interventions
within them. The last one is to offer specific support to inpatient women affected by CVD, who are
more susceptible than men to psychological problems such as anxiety and depression. In conclusion,
we believe it is fundamental to implement a virtuous model in hospitals with cardiovascular wards
where psychologists work together with physicians to provide patients with real bio-psycho-social
support, which, from assessment to treatment, could improve the patient’s treatment experience and
adherence, quality of life, and reduce the hospitalization time and the related costs.
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